Medical treatment options for endometriosis
book-chapter
OA: closed
CC0
AI-generated summary
Treatment of growth hormone-deficient children with GH resulted in a significantly improved final adult height compared to pretreatment and predicted heights.
One-sentence paraphrase of the abstract; not a substitute for reading it. No clinical advice. How this works
Abstract
With the introduction of recombinant human growth hormone (GH), GH-deficient (GHD) children have been treated with larger doses and in a continuous fashion and have been followed to final height. Near-adult height data were reported by Blethen et al. (1) in 121 GHD children who were prepubertal at the beginning of treatment; GHwas administered at a dose of 0.3mg/Kg/wk, initially three times weekly and then daily. The adult height standard deviation (SD) score was found to be 0.7 1.2, which was significantly greater than the pretreatment height SD score, the predicted adult height SD score, and the height SD score at the start of puberty. The etiology of GH-deficiency and the presence or absence of spontaneous puberty did not affect the outcome. Adult height in this study was positively dependent on height and negatively dependent on age at the start of the study; statistically significant variables included duration of treatment with GH, age and height at the start of GH and the growth rate during the first year of therapy.
My notes (saved in your browser only)
Condition tags
Citation neighborhood
Papers in the corpus that this work cites (lower rings, blue) and that cite this one (upper rings, green). Dot size scales with the paper's in-corpus citation count — bigger dot = more influential within the endo/adeno field. Click a dot to open that paper. [ expand to 2 hops ] — adds papers reached through this work's immediate citers/citees. Heavier; up to 60 extra dots.
References (38)
- A randomized, controlled trial of clomiphene citrate and intrauterine insemination in couples with unexplained infertility or surgically corrected endometriosis via openalex
- A Randomized, Parallel, Comparative Study of the Efficacy and Safety of Nafarelin Versus Danazol in the Treatment of Endometriosis in Taiwan via openalex
- Buserelin acetate versus expectant management in the treatment of infertility associated with minimal or mild endometriosis: A randomized clinical trial via openalex
- Clinical efficacy of the antiprogesterone RU486 in the treatment of endometriosis and uterine fibroids via openalex
- Danazol and medroxyprogesterone acetate inefficacious in the treatment of infertility in endometriosis via openalex
- Deep infiltrating endometriosis: relation between severity of dysmenorrhoea and extent of disease via openalex
- Gonadotropin-releasing hormone agonist plus “add-back” hormone replacement therapy for treatment of endometriosis: a prospective, randomized, placebo-controlled, double-blind trial via openalex
- Historical prospective cohort study of the recurrence of pain after discontinuation of treatment with danazol or a gonadotropin- releasing hormone agonist via openalex
- Intrapelvic injection of menstrual endometrium causes endometriosis in baboons (Papio cynocephalus and Papio anubis) via openalex
- Menotropin stimulation after prolonged gonadotropin releasing hormone agonist pretreatment for in vitro fertilization in patients with endometriosis via openalex
- Peritoneal endometriosis due to the menstrual dissemination of endometrial tissue into the peritoneal cavity via openalex
- Placebo-controlled comparison of danazol and high-dose medroxypro-gesterone acetate in the treatment of endometriosis after conservative surgery via openalex
- Post-operative GnRH analogue treatment after conservative surgery for symptomatic endometriosis stage III–IV: a randomized controlled trial via openalex
- Postsurgical medical treatment of advanced endometriosis: Results of a randomized clinical trial via openalex
- Prediction of pregnancy in infertile women based on the American Society for Reproductive Medicine's revised classification of endometriosis via openalex
- Prolonged GnRH agonist and add-back therapy for symptomatic endometriosis: long-term follow-up*1 via openalex
- Revised American Society for Reproductive Medicine classification of endometriosis: 1996 via openalex
- Simplified ultralong protocol of gonadotrophin-releasing hormone agonist for ovulation induction with intrauterine insemination in patients with endometriosis via openalex
- Subcutaneous injection of depot medroxyprogesterone acetate compared with leuprolide acetate in the treatment of endometriosis-associated pain via openalex
- The reproducibility of the revised American Fertility Society classification of endometriosis via openalex
- The Treatment of Endometriosis via openalex
- Treatment utilization for endometriosis symptoms: a cross-sectional survey study of lifetime experience via openalex
- Use of a levonorgestrel-releasing intrauterine device in the treatment of rectovaginal endometriosis via openalex
- Use of nafarelin versus placebo after reductive laparoscopic surgery for endometriosis via openalex
- Validation study of nonsurgical diagnosis of endometriosis via openalex
- What’s the delay? A qualitative study of women’s experiences of reaching a diagnosis of endometriosis via openalex
- W4235619221 via openalex
- W1618997004 via openalex
- W1910306760 via openalex
- W2004594777 via openalex
- W2028587418 via openalex
- W2063208090 via openalex
- W2080197694 via openalex
- W2152016833 via openalex
- W2159803441 via openalex
- W2411740592 via openalex
- W3188126663 via openalex
- W151784116 via openalex
Source provenance
- openalex
- last seen: 2026-06-10T17:14:06.276822+00:00
License: CC0
· commercial use OK